Usage of Rotarix┬« in Neonatal Units across the United Kingdom
- *Corresponding Author:
- Ignatius Losa
East Cheshire nhs Trust
Macclesfield, Cheshire, UK
Tel: 01625 421000
E-mail: [email protected]
Received Date: May 26 2014; Accepted Date: June 30 2014; Published Date: July 04 2014
Citation: Alsaffar H, Woodger K, Los I (2014) Usage of Rotarix® in Neonatal Units across the United Kingdom. J Vaccines Vaccin 5:240. doi: 10.4172/2157-7560.1000240
Copyright: © 2014 Alsaffar H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Following advice and recommendations by the Joint Committee on Vaccination and Immunisation (JCVI), and in line with standing commitments on patient rights under the NHS constitution on implementing such recommendations, a series of changes to England’s national immunisation programme took place from July 2013 including the introduction of Rotavirus vaccine (Rotarix® by GlaxoSmithKline Biologicals s.a.) into the routine childhood UK schedule for babies from 2 months of age .